Table 6.
Top 5 highly cited articles in the field of immunotherapy for bone malignancies.
| Rank | Title | DOI | Journal | IF (2022) | Publication year | Total citations |
|---|---|---|---|---|---|---|
| 1 | Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma | 10.1200/JCO.2014.58.0225 | Journal of Clinical Oncology | 45.3 | 2015 | 706 |
| 2 | CAR-T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors | 10.1158/1078-0432.CCR-18-0432 | Clinical Cancer Research | 11.5 | 2019 | 282 |
| 3 | Future directions in the treatment of osteosarcoma | 10.1097/MOP.0000000000000298 | Current Opinion in Pediatrics | 3.6 | 2016 | 223 |
| 4 | Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma | 10.1038/srep30093 | Scientific Reports | 4.6 | 2016 | 200 |
| 5 | Novel insights and therapeutic interventions for pediatric osteosarcoma | 10.2217/fon-2016-0261 | Future Oncology | 3.4 | 2017 | 174 |